Asthma Research Study

6327 SE Milwaukie Avenue near Tolman, Portland OR

Description

If you are experiencing wheezing, coughing and shortness of breath despite the use of a daily asthma ICS treatment regimen, you may be eligible to enroll in this research study at Northwest Research Center. Eligibility criteria includes: • Ages 12-80 years old • Physician-diagnosed asthma for at least 6 months (1 year for adolescents) • Current daily use of inhaled corticosteroid (ICS) such as QVAR, Flovent, Pulmicort or ICS/LABA regimen such as Symbicort, Advair, Dulera, Breo • No use of any forms of tobacco, vaping devices, or marijuana Additional criteria may apply. Health insurance and doctor referrals are not required to participate. Those who qualify will receive investigational medication and study-related care at no cost and may be compensated for study-related time and travel. To learn more about this research study, please complete the form or contact our research department at: Northwest Research Center 6327 SE Milwaukie Avenue, 2nd Floor Portland, OR 97202 PH: www.nw-research.com